Andere Sprachen Bioretec Oy

Aktien

A3C4QB

FI4000480454

BRETEC

Verzögert Nasdaq Helsinki Andere Börsenplätze 12:02:52 21.05.2024			% 5 Tage	% 1. Jan.
2,63 ^EUR	-1,87 %		-2,23 %	+9,58 %

08:14	Medizintechnikunternehmen Bioretec ernennt neuen CEO	MT
05.04.	Bioretec Oy gibt bekannt, dass Pekka Simula für eine Wiederwahl in den Verwaltungsrat nicht zur Verfügung steht	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Medical Device Company Bioretec Names New CEO	08:14
Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (Stephen Industries Inc Oy)	20.05.
Inside information: Alan Donze has been appointed as Bioretec's new CEO	20.05.
Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses	16.05.
Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors	26.04.
Notice of Annual General Meeting (AGM) of Bioretec Ltd	08.04.
Notice of Annual General Meeting (AGM) of Bioretec Ltd	05.04.
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	05.04.
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	22.03.
Inside information: Bioretec's RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office	21.03.
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	21.03.
Bioretec Ltd's Annual Report and Financial Statements 2023 published	15.03.
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant	14.03.
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage	14.03.
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	14.03.
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	11.03.
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	08.03.
Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory	16.02.
Bioretec and Stephen Industries donate medical devices to Ukraine	08.02.
New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register	18.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bioretec Oy

Aktien

A3C4QB

FI4000480454

BRETEC

Andere Sprachen

Filter